NEW York Dialysis Services Inc. in Brooklyn, New York - Dialysis Center

NEW York Dialysis Services Inc. is a medicare approved dialysis facility center in Brooklyn, New York and it has 49 dialysis stations. It is located in Kings county at 595 Degraw Street, Brooklyn, NY, 11217. You can reach out to the office of NEW York Dialysis Services Inc. at (718) 852-0197. This dialysis clinic is managed and/or owned by Fresenius Medical Care. NEW York Dialysis Services Inc. has the following ownership type - Profit. It was first certified by medicare in February, 2017. The medicare id for this facility is 332745 and it accepts patients under medicare ESRD program.

Name	NEW York Dialysis Services Inc.
Location	595 Degraw Street, Brooklyn, New York
No. of Dialysis Stations	49
Medicare ID	332745
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with NEW York Dialysis Services Inc. from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1578685111
Organization Name	Fms-atlantic Hemodialysis Center
Doing Business As	New York Dialysis Services, Inc.
Address	595 Degraw St Brooklyn, New York, 11217
Phone Number	(718) 852-6672

NPI Number	1609325349
Organization Name	Fresenius Kidney Care Degraw Street
Doing Business As	New York Dialysis Services, Inc.
Address	595 Degraw St Brooklyn, New York, 11217
Phone Number	(718) 852-0197

Dialysis patients with Hemoglobin data	30
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL	30

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	69
  Adult patient months included in Kt/V greater than or equal to 1.2	375
  Percentage of adult patients getting regular hemodialysis at the center	90
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at NEW York Dialysis Services Inc. with elevated calcium levels.

Patients with hypercalcemia	71
Hypercalcemia patient months	380
Hypercalcemia patients with serumcalcium greater than 10.2 mg	1
Patients with Serumphosphor	79
Patients with Serumphosphor less than 3.5 mg/dL	9
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	23
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	31
Patients with Serumphosphor from 5.6 to 7 mg/dL	30
Patients with Serumphosphor greater than 7 mg/dL	7

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	65
Patient months included in arterial venous fistula and catheter summaries	296
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	58
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	13